Early and prolonged oral edaravone for neuroprotection in acute ischemic stroke: the ERASE-STROKE randomized controlled phase 3 trial.
- DOI
- 10.1016/j.scib.2026.08.038
- Published
- 2026 Aug 22
- Container
- Science bulletin
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1016/j.scib.2026.08.038,
title = {Early and prolonged oral edaravone for neuroprotection in acute ischemic stroke: the ERASE-STROKE randomized controlled phase 3 trial.},
author = {Xiang Y and Jin WS and Zhu XC and Song Y and Chen X and Wang QH and Sun HL and Zhao Y and Yu XR and Feng T and Guo AH and Dai HG and Huang HN and Fang JX and Wang MH and Peng YM and Liu XM and Bu XL and Liu YH and Zhang M and Anderson CS and Nogueira RG and He WL and Zhou XF and Wang YJ and ERASE-STROKE investigators},
year = {2026},
journal = {Science bulletin},
doi = {10.1016/j.scib.2026.08.038},
url = {https://doi.org/10.1016/j.scib.2026.08.038}
}RIS
TY - JOUR TI - Early and prolonged oral edaravone for neuroprotection in acute ischemic stroke: the ERASE-STROKE randomized controlled phase 3 trial. AU - Xiang Y AU - Jin WS AU - Zhu XC AU - Song Y AU - Chen X AU - Wang QH AU - Sun HL AU - Zhao Y AU - Yu XR AU - Feng T AU - Guo AH AU - Dai HG AU - Huang HN AU - Fang JX AU - Wang MH AU - Peng YM AU - Liu XM AU - Bu XL AU - Liu YH AU - Zhang M AU - Anderson CS AU - Nogueira RG AU - He WL AU - Zhou XF AU - Wang YJ AU - ERASE-STROKE investigators PY - 2026 JO - Science bulletin DO - 10.1016/j.scib.2026.08.038 UR - https://doi.org/10.1016/j.scib.2026.08.038 ER -
APA
Y, X., WS, J., XC, Z., Y, S., X, C., QH, W., HL, S., Y, Z., XR, Y., T, F., AH, G., HG, D., HN, H., JX, F., MH, W., YM, P., XM, L., XL, B., YH, L., M, Z., CS, A., RG, N., WL, H., XF, Z., YJ, W., & investigators, E. (2026). Early and prolonged oral edaravone for neuroprotection in acute ischemic stroke: the ERASE-STROKE randomized controlled phase 3 trial.. Science bulletin. https://doi.org/10.1016/j.scib.2026.08.038
Source records
- pubmed · retrieved 2026-09-26T01:40:54.226Z